These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 11846487
1. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling. Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A. Dev Biol; 2002 Mar 01; 243(1):185-206. PubMed ID: 11846487 [Abstract] [Full Text] [Related]
2. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D. Nat Genet; 1996 Mar 01; 12(3):241-7. PubMed ID: 8589713 [Abstract] [Full Text] [Related]
3. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. Veugelers M, Vermeesch J, Watanabe K, Yamaguchi Y, Marynen P, David G. Genomics; 1998 Oct 01; 53(1):1-11. PubMed ID: 9787072 [Abstract] [Full Text] [Related]
4. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition. DeBaun MR, Ess J, Saunders S. Mol Genet Metab; 2001 Apr 01; 72(4):279-86. PubMed ID: 11286501 [Abstract] [Full Text] [Related]
5. glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Paine-Saunders S, Viviano BL, Zupicich J, Skarnes WC, Saunders S. Dev Biol; 2000 Sep 01; 225(1):179-87. PubMed ID: 10964473 [Abstract] [Full Text] [Related]
6. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J. J Cell Biol; 1999 Jul 12; 146(1):255-64. PubMed ID: 10402475 [Abstract] [Full Text] [Related]
9. Overgrowth syndromes and genomic imprinting: from mouse to man. Li M, Squire JA, Weksberg R. Clin Genet; 1998 Mar 12; 53(3):165-70. PubMed ID: 9630066 [Abstract] [Full Text] [Related]
11. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family. Xuan JY, Hughes-Benzie RM, MacKenzie AE. J Med Genet; 1999 Jan 12; 36(1):57-8. PubMed ID: 9950367 [Abstract] [Full Text] [Related]
12. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Murthy SS, Shen T, De Rienzo A, Lee WC, Ferriola PC, Jhanwar SC, Mossman BT, Filmus J, Testa JR. Oncogene; 2000 Jan 20; 19(3):410-6. PubMed ID: 10656689 [Abstract] [Full Text] [Related]
13. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo. Hartwig S, Hu MC, Cella C, Piscione T, Filmus J, Rosenblum ND. Mech Dev; 2005 Jul 20; 122(7-8):928-38. PubMed ID: 15925496 [Abstract] [Full Text] [Related]
14. Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. Hughes-Benzie RM, Pilia G, Xuan JY, Hunter AG, Chen E, Golabi M, Hurst JA, Kobori J, Marymee K, Pagon RA, Punnett HH, Schelley S, Tolmie JL, Wohlferd MM, Grossman T, Schlessinger D, MacKenzie AE. Am J Med Genet; 1996 Dec 11; 66(2):227-34. PubMed ID: 8958336 [Abstract] [Full Text] [Related]
18. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Cell; 1993 Oct 08; 75(1):59-72. PubMed ID: 8402901 [Abstract] [Full Text] [Related]
19. Glypican-3 expression is silenced in human breast cancer. Xiang YY, Ladeda V, Filmus J. Oncogene; 2001 Nov 01; 20(50):7408-12. PubMed ID: 11704870 [Abstract] [Full Text] [Related]